Literature DB >> 22791954

An unusual case of fatty liver in a patient with desmoid tumor.

Francesca De Felice1, Daniela Musio, Rossella Caiazzo, Bartolomeo Dipalma, Lavinia Grapulin, Camilla Proietti Semproni, Vincenzo Tombolini.   

Abstract

A desmoid tumor, also known as aggressive fibromatosis, is a rare benign neoplasm that arises from fascial or musculoaponeurotic tissues. It can occur in any anatomical location, most commonly the abdominal wall, shoulder girdle and retroperitoneum. The typical clinical presentation is a painless mass with a slow and progressive invasion of contiguous structures. It is associated with a high local recurrence rate after resection. Many issues regarding the optimal treatment of desmoid tumors remain controversial. Aggressive surgical resection with a wide margin (2-3 cm) remains the gold standard treatment with regard to preserving quality of life. Radiotherapy alone has been shown to be effective for the control of unresectable or recurrent lesions. Desmoid tumors tend to be locally infiltrative, therefore, the fields must be generous to prevent marginal recurrence. The radiation dose appropriate for treating desmoid tumors remains controversial. We present a 25-year-old Caucasian man with local recurrence of a desmoid tumor after repeated surgical resection, treated with radiotherapy. The patient achieved complete tumor regression at 4 mo after radiotherapy, and he is clinically free of disease at 12 mo after the end of treatment, with an acceptable quality of life. The patient developed short bowel syndrome as a complication of second surgical resection. Consequently, radiotherapy might have worsened an already present malabsorption and so led to steatohepatitis.

Entities:  

Keywords:  Aggressive fibromatosis; Desmoid tumor; Fatty liver

Mesh:

Year:  2012        PMID: 22791954      PMCID: PMC3386332          DOI: 10.3748/wjg.v18.i24.3173

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national Patterns of Care Study.

Authors:  Oliver Micke; M Heinrich Seegenschmiedt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

2.  Case 84: desmoid tumor of the abdominal wall.

Authors:  Harvey E L Teo; Wilfred C G Peh; Tony W H Shek
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

Review 3.  Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature.

Authors:  Saskia Buitendijk; Cees P van de Ven; Ton G Dumans; Jan C den Hollander; Peter J Nowak; Wim J Tissing; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Cancer       Date:  2005-09-01       Impact factor: 6.860

4.  Aggressive fibromatosis.

Authors:  J B Ackman; G J Whitman; F S Chew
Journal:  AJR Am J Roentgenol       Date:  1994-09       Impact factor: 3.959

5.  Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.

Authors:  Colleen Wu; Saeid Amini-Nik; Saied Nik-Amini; Puviindran Nadesan; William L Stanford; Benjamin A Alman
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

6.  Desmoid tumors in adults: the role of radiotherapy in their management.

Authors:  J P Bataini; C Belloir; A Mazabraud; J P Pilleron; A Cartigny; C Jaulerry; N A Ghossein
Journal:  Am J Surg       Date:  1988-06       Impact factor: 2.565

7.  Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors).

Authors:  K D Kiel; H D Suit
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

8.  Desmoid tumors--treatment and prognosis.

Authors:  W M Wara; T L Phillips; D R Hill; E Bovill; K H Luk; A S Lichter; S A Leibel
Journal:  Radiology       Date:  1977-07       Impact factor: 11.105

9.  Treatment of aggressive fibromatosis: the experience of a single institution.

Authors:  M El-Haddad; M El-Sebaie; R Ahmad; E Khalil; M Shahin; R Pant; M Memon; A Al-Hebshi; Y Khafaga; M Al-Shabanah; A Allam
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-10-28       Impact factor: 4.126

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.